Search

everythinglearnresearchcommunity

for

Search:↓

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

ITK inhibitors may effectively treat alopecia areata.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Hsa-miR-193a-5p is important in alopecia areata by promoting inflammation and involving specific genes in hair and immune function.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

BMS-470539 reduces skin fibrosis and inflammation.

New and repurposed treatments are improving outcomes in dermatology.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Certain microRNAs found in normal cells can effectively suppress various cancers.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.